Metabolon
Metabolon Raises $25M in Private Equity Financing
The Morrisville, North Carolina-based company, which was founded in 2000, offers metabolomics-based services for drug development and biomarker discovery.
Metabolon, Parkinson's UK Form Biomarker Discovery Alliance
Metabolon will participate in a Parkinson's UK-funded study to map metabolic changes in serum that can serve as biomarkers of disease progression.
Metabolon, NTU Singapore Partner for Disease Biomarker Discovery Study
Metabolon will access data from the Nanyang Technological University-led study to identify biomarkers for a range of health conditions.
Metabolon, University of Oxford Parkinson's Disease Centre Strike Research Partnership
The collaborators hope that understanding metabolic changes associated with Parkinson's will shed light on the disease.
Metabolon, University of Maryland School of Medicine Partner for Amish Study
The collaborators aim to integrate metabolomics into genomic and clinical datasets in this unique population to understand incidental disease.